A Putative "hepitype" in the ATM Gene Associated with Chronic Lymphocytic Leukemia Risk

被引:4
作者
Martin-Guerrero, Idoia [1 ]
Enjuanes, Anna [2 ]
Richter, Julia [3 ,4 ]
Ammerpohl, Ole [3 ,4 ]
Colomer, Dolors [2 ]
Ardanaz, Maite [5 ]
Marco, Fernando [6 ]
Salas, Antonio [7 ,8 ]
Campo, Elias [2 ]
Siebert, Reiner [3 ,4 ]
Garcia-Orad, Africa [1 ]
机构
[1] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa 48940, Bizkaia, Spain
[2] Univ Barcelona, Hosp Clin, Dept Anat Pathol, Inst Invest Biomed August Pi & Sunyer,Hematopatho, Barcelona, Spain
[3] Univ Kiel, Inst Human Genet, Kiel, Germany
[4] Univ Hosp Schleswig Holstein, Campus Kiel, Germany
[5] Hosp Txagorritxu, Vitoria, Alava, Spain
[6] Hosp Basurto, Bilbao, Vizcaya, Spain
[7] Univ Santiago Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain
[8] Univ Santiago Compostela, Fac Med, Dept Anat Patolox Ciencias Forenses, Galicia, Spain
关键词
DNA METHYLATION; DOWN-REGULATION; BREAST-CANCER; VARIANTS; CELL; GENOME; HYPERMETHYLATION; HAPLOTYPES; LYMPHOMA; TRANSCRIPTION;
D O I
10.1002/gcc.20912
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic lymphocytic leukemia (CLL) cells are characterized by several chromosomal lesions. Some of these aberrations imply chromosome breaks as a result of unrepaired double strand breaks (DSBs) in the DNA. The ATM (ataxia telangiectasia-mutated) protein is the principal integrator of cellular responses to DSBs. ATM deletion is also an adverse prognostic factor in CLL. Taking this into account, we evaluated if genetic and/or epigenetic variation in the ATM gene may modulate the individual susceptibility to develop CLL. Our case-control association study was performed in a large Spanish population of 1,503 individuals, including 742 patients with CLL and 761 controls. We identified one haplotype within the ATM gene that confers an increased risk of CLL development (OR = 1.33; 95% Cl: 1.10-1.60). Two polymorphisms of this ATM haplotype eliminated one CpG site each in Introns 15 and 61, causing changes in DNA methylation pattern. These data provide the first evidence for the existence of a putative "hepitype" in the ATM gene associated with CLL risk. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:887 / 895
页数:9
相关论文
共 50 条
  • [31] Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
    Berndt, Sonja I.
    Skibola, Christine F.
    Joseph, Vijai
    Camp, Nicola J.
    Nieters, Alexandra
    Wang, Zhaoming
    Cozen, Wendy
    Monnereau, Alain
    Wang, Sophia S.
    Kelly, Rachel S.
    Lan, Qing
    Teras, Lauren R.
    Chatterjee, Nilanjan
    Chung, Charles C.
    Yeager, Meredith
    Brooks-Wilson, Angela R.
    Hartge, Patricia
    Purdue, Mark P.
    Birmann, Brenda M.
    Armstrong, Bruce K.
    Cocco, Pierluigi
    Zhang, Yawei
    Severi, Gianluca
    Zeleniuch-Jacquotte, Anne
    Lawrence, Charles
    Burdette, Laurie
    Yuenger, Jeffrey
    Hutchinson, Amy
    Jacobs, Kevin B.
    Call, Timothy G.
    Shanafelt, Tait D.
    Novak, Anne J.
    Kay, Neil E.
    Liebow, Mark
    Wang, Alice H.
    Smedby, Karin E.
    Adami, Hans-Olov
    Melbye, Mads
    Glimelius, Bengt
    Chang, Ellen T.
    Glenn, Martha
    Curtin, Karen
    Cannon-Albright, Lisa A.
    Jones, Brandt
    Diver, W. Ryan
    Link, Brian K.
    Weiner, George J.
    Conde, Lucia
    Bracci, Paige M.
    Riby, Jacques
    NATURE GENETICS, 2013, 45 (08) : 868 - 876
  • [32] Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia
    Crowther-Swanepoel, Dalemari
    Qureshi, Mobshra
    Dyer, Martin J. S.
    Matutes, Estella
    Dearden, Claire
    Catovsky, Daniel
    Houlston, Richard S.
    BLOOD, 2009, 114 (23) : 4843 - 4846
  • [33] Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia
    Tomic, Jelena
    Lichty, Brian
    Spaner, David E.
    BLOOD, 2011, 117 (09) : 2668 - 2680
  • [34] Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine
    Cejkova, Sona
    Rocnova, Ludmila
    Potesil, David
    Smardova, Jana
    Novakova, Vera
    Chumchalova, Jitka
    Zezulkova, Dita
    Borsky, Marek
    Doubek, Michael
    Brychtova, Yvona
    Pospisilova, Sarka
    Klabusay, Martin
    Mayer, Jiri
    Trbusek, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (02) : 133 - 142
  • [35] DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia
    Wang, Lu Qian
    Chim, Chor Sang
    EPIGENOMICS, 2015, 7 (03) : 461 - 473
  • [36] Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia
    Akimova, Ekaterina
    Gassner, Franz Josef
    Greil, Richard
    Zaborsky, Nadja
    Geisberger, Roland
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [37] Recent advances in microRNA-mediated gene regulation in chronic lymphocytic leukemia
    Srivastava, Swati
    Tsongalis, Gregory J.
    Kaur, Prabhjot
    CLINICAL BIOCHEMISTRY, 2013, 46 (10-11) : 901 - 908
  • [38] MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion
    Hernandez-Sanchez, Maria
    Rodriguez-Vicente, Ana E.
    Hernandez, Jose-Angel
    Lumbreras, Eva
    Sarasquete, Maria-Eugenia
    Martin, Ana-Africa
    Benito, Rocio
    Vicente-Gutierrez, Carlos
    Robledo, Cristina
    de las Heras, Natalia
    Rodriguez, Juan-Nicolas
    Alcoceba, Miguel
    Garcia de Coca, Alfonso
    Aguilar, Carlos
    Gonzalez, Marcos
    Hernandez-Rivas, Jesus-Maria
    LEUKEMIA RESEARCH, 2016, 46 : 30 - 36
  • [39] Recent advances in chronic lymphocytic leukemia
    Vyas, N.
    Hassan, A.
    INDIAN JOURNAL OF CANCER, 2012, 49 (01) : 137 - 143
  • [40] Clinical Risks for Chronic Lymphocytic Leukemia
    Brown, Jennifer R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (03):